Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 4/26/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Antony Blanc?

Antony Blanc

Vice President, Integration Lead (Novartis Vaccines Acquisition)

GSK Biologicals

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

GSK Biologicals

Background Information

Employment History

Vice President, Global Commercial Lead NicVax

Synosia Therapeutics


Vice President Business Development

Synt


Head

BioPharma Alliance LLC


Senior Engagement Manager

McKinsey & Company


Head of Biopharma

Syngenta AG


Web References(22 Total References)


Synosia Therapeutics

www.synosia.com [cached]

Antony Blanc
Chief Business Officer Tel: +41 61 206 9203 Fax: +41 61 206 9201 Email: ablanc@synosia.com


Synosia Therapeutics

www.synosia.com [cached]

A molecular biologist by training and an experienced biotech entrepreneur, Dr. Blanc also helped biotech and pharma clients with R&D, commercial and strategy issues as associate partner with the business consultants McKinsey & Company.
In his 13 years in the pharmaceutical and biotech industry, he has worked at the interface between strategy, research and development management, business development and operational delivery. Antony, who also heads Synosia's Basel operation, most recently served as head of biopharma for Syngenta, a world leading agribusiness based in Basel, where he built a pipeline of eight projects within 24 months. Previously, he was vice president of business development at Synt:em in France where he established strategic alliances and out-licensed the company's technologies and products. Antony earned his bachelor's of science degree in biochemistry with a minor in biotechnology and his doctorate in molecular biology from McGill University in Montreal, Canada.


Ian Massey Email Synosia Therapeutics CEO CFO VP @synosia.com

www.lead411.com [cached]

Antony Blanc [VCard] Chief Business Officer


www.newswire.ca

appointment of Antony Blanc, Ph.D., as the company's new chief business officer, effective immediately. Dr Blanc, who will serve as head of Synosia's office in Basel, Switzerland, joins from Syngenta, where he created and led the biopharmaceuticals business unit.A molecular biologist by training and an experienced biotech entrepreneur, Dr. Blanc helped biotech and pharma clients with R&D, commercial and strategy issues as associate partner with the business consultants McKinsey & Company. "With a strong entrepreneurial flair in biotech and expertise in both science and business, Antony Blanc brings together the skills we need to lead company" said Blanc. Antony Blanc replaces Herve Girsault M.B.A., who will remain on Synosia's


www.prnewswire.com

SAN FRANCISCO, December 13 /PRNewswire/ -- Synosia Therapeutics today announced the appointment of Antony Blanc, Ph.D., as the company's new chief business officer, effective immediately. Dr Blanc, who will serve as head of Synosia's office in Basel, Switzerland, joins from Syngenta, where he created and led the biopharmaceuticals business unit.A molecular biologist by training and an experienced biotech entrepreneur, Dr. Blanc helped biotech and pharma clients with R&D, commercial and strategy issues as associate partner with the business consultants McKinsey & Company. "With a strong entrepreneurial flair in biotech and expertise in both science and business, Antony Blanc brings together the skills we need to specialty pharma company" said Blanc. Antony Blanc replaces Herve Girsault M.B.A., who will remain on


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory